benzimidazol-2-one has been researched along with gsk 1034702 in 1 studies
Studies (benzimidazol-2-one) | Trials (benzimidazol-2-one) | Recent Studies (post-2010) (benzimidazol-2-one) | Studies (gsk 1034702) | Trials (gsk 1034702) | Recent Studies (post-2010) (gsk 1034702) |
---|---|---|---|---|---|
18 | 0 | 9 | 6 | 1 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradley, SJ; Broad, LM; Brooke, SM; Bundgaard, C; Christopoulos, A; Crabtree, MD; Dwomoh, L; Felder, CC; Langmead, CJ; Mogg, AJ; Molloy, C; Sanger, HE; Sexton, PM; Thompson, KJ; Tobin, AB | 1 |
1 other study(ies) available for benzimidazol-2-one and gsk 1034702
Article | Year |
---|---|
Bitopic Binding Mode of an M
Topics: Acetylcholine; Allosteric Regulation; Allosteric Site; Alzheimer Disease; Animals; Benzimidazoles; Binding Sites; Cell Line; CHO Cells; Clinical Trials as Topic; Cricetinae; Cricetulus; Humans; Learning; Male; Memory; Mice; Mice, Inbred C57BL; Muscarinic Agonists; Protein Binding; Rats; Rats, Wistar; Receptor, Muscarinic M1; Receptors, Muscarinic | 2018 |